Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
Stopped PI changed institution. Not yet approved at current location.
Conditions
- Extensive-stage Small-cell Lung Cancer
Interventions
- DRUG: Durvalumab 50 MG/1 ML Intravenous Solution
- DRUG: Etoposide Injection
- DRUG: Cisplatin
- DRUG: Carboplatin
- DEVICE: Stereotactic Body Radiotherapy
Sponsor
University of Maryland, Baltimore
Collaborators